Botox Coding & Billing 2026: CPT Codes, J0585, and Reimbursement Guidelines

Quick Reference: Botox Coding

• Drug Code: J0585 (Injection, onabotulinumtoxinA, 1 unit). Bill exact units used.
• Waste Modifier: Use JW for wastage on a separate line; use JZ if no waste occurred (Medicare).
• Migraine Code: 64615 (Includes face, neck, and head muscles). Do NOT bill with 64616/64612.
• Frequency Limit: Generally 12 weeks (3 months) between sessions.
• Cosmetic: Not covered. Bill with modifier GY to get a denial for secondary insurance if needed.

Botox® (onabotulinumtoxinA) injections are used in a variety of therapeutic medical conditions as well as for cosmetic purposes. Proper coding of Botox procedures is critical for accurate billing and reimbursement.

This guide breaks down the 2025–2026 CPT® codes, differentiates between drug and procedure billing, and clarifies the complex “waste” modifiers required by Medicare.

CPT Codes for Botox Injection Procedures

flowchart TD
    A[Botox Injection] --> B{Anatomic Region?}
    B --> C[Head/Neck]
    B --> D[Limbs]
    B --> E[Trunk]
    B --> F[Autonomic/Urological]

    C --> C1{Indication?}
    C1 --> C2[Chronic Migraine] --> C2a[64615 bilateral]
    C1 --> C3[Blepharospasm/Facial] --> C3a[64612 unilateral]
    C1 --> C4[Cervical Dystonia] --> C4a[64616 unilateral]
    C1 --> C5[Larynx] --> C5a[64617]

    D --> D1{Muscles per extremity?}
    D1 --> D2[1-4 muscles] --> D2a[64642]
    D1 --> D3[5+ muscles] --> D3a[64644]
    D --> D4[Additional extremity?]
    D4 --> D5[1-4 add-on] --> D5a[+64643]
    D4 --> D6[5+ add-on] --> D6a[+64645]

    E --> E1{Muscle count?}
    E1 --> E2[1-5 muscles] --> E2a[64646]
    E1 --> E3[6+ muscles] --> E3a[64647]

    F --> F1[Sialorrhea] --> F1a[64611]
    F --> F2[Overactive Bladder] --> F2a[52287]
    F --> F3[Hyperhidrosis Axillae] --> F3a[64650]
    F --> F4[Hyperhidrosis Other] --> F4a[64653]

Coding for the injection is separate from the drug. Select the procedure code based on the anatomy treated.

Head and Neck Muscle Injections

• 64612: Chemodenervation of muscle(s) innervated by the facial nerve, unilateral (e.g., Blepharospasm, Hemifacial spasm).

Tip: Use Modifier 50 for bilateral.

• 64615: Chemodenervation of muscles innervated by facial, trigeminal, cervical spinal, and accessory nerves, bilateral.

Usage: Specific for Chronic Migraine prophylaxis. Do not report with 64612 or 64616.

• 64616: Chemodenervation of neck muscle(s), unilateral (e.g., Cervical Dystonia).

Tip: Includes sternocleidomastoid, trapezius, splenius.

• 64617: Chemodenervation of larynx (vocal cords), unilateral, percutaneous. Includes EMG guidance.

Limb and Trunk (Spasticity & Dystonia)

Codes are selected based on the number of muscles injected per extremity.

Autonomic & Urological Injections

• 64611: Chemodenervation of parotid and submandibular salivary glands, bilateral (Sialorrhea).
• 52287: Cystourethroscopy with injection into bladder wall (Overactive Bladder).
• 64650: Chemodenervation of eccrine glands; both axillae (Hyperhidrosis).
• 64653: Chemodenervation of eccrine glands; other areas (Scalp, Face).

Drug Coding: J0585 & Wastage Rules

The procedure code pays for the work of injecting. The HCPCS code pays for the toxin.

Unit Conversion Alert: J0585 is billed per 1 Unit. If you inject 100 units, you bill J0585 x 100. (Note: Dysport J0586 is billed per 5 units).

The JW and JZ Modifiers

Medicare (and many commercial payers) require you to account for single-use vials.

• Scenario: You open a 200-unit vial. You inject 150 units. You discard 50 units.
• Line 1: J0585 x 150 (Amount administered).
• Line 2: J0585-JW x 50 (Amount wasted).
• Line 3 (If no waste): If you use the exact amount in the vial (rare), append modifier JZ to attest no waste occurred.

Common Indications and ICD-10 Codes

Chronic Migraine (G43.7x)

FDA approved for prophylaxis of headaches in adults with ≥15 headache days per month.

ICD-10: G43.709 (Chronic migraine without aura, not intractable).

Code: 64615 (covers the specific 31-site protocol).

Cervical Dystonia (G24.3)

Involuntary contraction of neck muscles.

Code: 64616 (Neck muscles). Use Modifier 50 if bilateral.

Limb Spasticity (I69.x / G80.x)

Common in stroke (I69.35x) or Cerebral Palsy (G80.x).

Code: 64642-64645.

Documentation: Must show functional limitation and failure of oral antispastics.

Hyperhidrosis (L74.5x)

Severe primary axillary sweating.

Code: 64650 (Axillae).

Note: Many payers require failure of clinical-strength topical antiperspirants first.

2025–2026 Reimbursement Guidelines

Frequency Limits (The 12-Week Rule)

Payers generally limit therapeutic Botox to once every 12 weeks (90 days) per anatomic site.

Exception: If treating different regions (e.g., Bladder one month, Migraine the next), this may be allowed, but check local policies (LCDs).

Prior Authorization (PA)

• Commercial/Medicare Advantage: Almost always requires PA. Schedule patients 3-4 weeks out to allow time.
• Hospital Outpatient: Medicare now requires PA for 64612/64615 in the hospital outpatient setting to prevent cosmetic abuse.

Billing Tips and Modifier Usage

Modifier 50 (Bilateral)

Used for unilateral codes (64612, 64616) when performed on both sides.

Note: Do NOT use 50 on 64615 (Migraine) or 64650 (Hyperhidrosis) as these descriptions already state “bilateral” or “both.”

Modifier 59 / XS (Distinct Service)

Use if injecting distinct anatomic regions that might otherwise bundle.

Example: Injecting neck for Dystonia (64616) and Leg for Spasticity (64642) in same session.

Modifier 25 (Significant E/M)

Only use if a significant, separately identifiable evaluation was performed above and beyond the standard pre-injection assessment.

Example: Patient comes for Botox (Migraine) but also requires management for new onset vertigo.